glucagon

RxCUI 4832 ingredient

Contraindicated with · 22

Diagnoses11

Adenoma, Islet Cell Insulinoma Adenoma Paraganglioma Pheochromocytoma Neuroendocrine Tumors Neuroectodermal Tumors Neoplasms, Nerve Tissue Neoplasms, Germ Cell and Embryonal Neoplasms, Glandular and Epithelial Drug Hypersensitivity

Condition families11

Pancreatic Neoplasms Pancreatic Diseases Endocrine Gland Neoplasms Digestive System Neoplasms Neoplasms by Histologic Type Endocrine System Diseases Neoplasms by Site Neoplasms Digestive System Diseases Drug-Related Side Effects and Adverse Reactions Chemically-Induced Disorders

Indicated for · 23

Diagnoses14

Anaphylaxis Hypoglycemia Shock, Cardiogenic Bradycardia Shock Hypotension Myocardial Infarction Infarction Ischemia Necrosis Arrhythmias, Cardiac Myocardial Ischemia Hypersensitivity, Immediate Hypersensitivity

Condition families9

Glucose Metabolism Disorders Heart Diseases Metabolic Diseases Vascular Diseases Nutritional and Metabolic Diseases Cardiovascular Diseases Pathologic Processes Immune System Diseases Pathological Conditions, Signs and Symptoms

MED-RT, published by the VA through NLM. Relationships attach at the ingredient level, not to a specific product or dose.

RADV audits Coding jobs Chart counter Hours & decimal time About Contact Help Terms Privacy

Innova Coding Suite extension — both tools in your browser: Add to Chrome · Add to Edge

InnovaRx — Innova Health Strategies. ICD-10-CM and the CMS-HCC risk adjustment models are published by CMS and NCHS and are in the public domain. Effective date 2026-10-22 travels in the URL, so this link shows anyone exactly what you see.